BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28867381)

  • 1. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
    Weksler B; Kennedy KF; Sullivan JL
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1787-1793. PubMed ID: 28867381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer.
    Merkow RP; Bilimoria KY; Keswani RN; Chung J; Sherman KL; Knab LM; Posner MC; Bentrem DJ
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25031273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study.
    Marino KA; Sullivan JL; Weksler B
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2211-2218.e1. PubMed ID: 29455958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.
    Lee L; Ronellenfitsch U; Hofstetter WL; Darling G; Gaiser T; Lippert C; Gilbert S; Seely AJ; Mulder DS; Ferri LE
    J Am Coll Surg; 2013 Aug; 217(2):191-9. PubMed ID: 23659947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.
    Boys JA; Worrell SG; Chandrasoma P; Vallone JG; Maru DM; Zhang L; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Molena D; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):6-12; discussion 12. PubMed ID: 26408330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases.
    Molena D; Schlottmann F; Boys JA; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Mungo B; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2017 Jan; 21(1):62-67. PubMed ID: 27561633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
    Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH
    J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
    Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
    Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
    Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
    Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Treatment of T1N0 Esophageal Cancer.
    Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
    Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
    Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
    Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients.
    Oetzmann von Sochaczewski C; Haist T; Pauthner M; Mann M; Fisseler-Eckhoff A; Braun S; Ell C; Lorenz D
    Dis Esophagus; 2019 Nov; 32(9):. PubMed ID: 30596900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.
    Nobel TB; Barbetta A; Hsu M; Tan KS; Sihag S; Bains MS; Jones DR; Molena D
    J Am Coll Surg; 2019 Oct; 229(4):366-373. PubMed ID: 31108196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
    Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
    J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
    Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.